Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

OTHER 8 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Drug Therapy 10 pembrolizumab 9 Bevacizumab 9 Radiotherapy 8 Cyclophosphamide 8 Carboplatin 8 Oxaliplatin 7 tislelizumab 6 Surgical Procedures, Operative 6 Docetaxel 6 Cisplatin 6 Capecitabine 6 Paclitaxel 5 Nivolumab 5 Fluorouracil 5 Control Groups 5 fludarabine 4 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Endoscopic Mucosal Resection 4 sintilimab 3 Trastuzumab 3 Pemetrexed 3 Neoadjuvant Therapy 3 Leucovorin 3 Laparoscopy 3 Irinotecan 3 Injections 3 Hematologic Tests 3 HMPL-013 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × TP protocol × Clear all

NCT04138212 2022-08-09

HCHTOG1903

Henan Cancer Hospital

Phase 3 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡